|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Eur J Cardiothorac Surg 2006;30:414
© 2006 Elsevier Science NL
Letter to the Editor |
Department of Pediatric Cardiac Surgery of Guatemala (UNICARP), 9a Avenida, 8-00 Zone 11, Guatemala City, Guatemala
Received 4 May 2006; accepted 5 May 2006.
* Corresponding author. (Email: vladimirovida{at}interfree.it).
Key Words: Prosthetic graft Innominate vein Cavopulmonary shunt
Our experience with modified BlalockTaussig shunts into very small pulmonary artery branches has not been good. The shunts can cause distortion, kinking, etc., and they do not always allow for increases in pulmonary artery size. Also, since we were envisioning a future Fontan-type repair, the right pulmonary artery was extremely important to preserve, as well as the protection of the pulmonary arteries from pulmonary vascular obstructive disease.
The wisdom of this strategy was proven by the increase in size of the right pulmonary artery after the goretex interposition [1] from 3 mm to 6 mm (Z-value of the right pulmonary artery from 3.8 to 0.5) by 10 months. Excellent flow was also achieved from the right superior vena cava via the enlarged right pulmonary artery to the right lung.
The risk of thrombosis of a systemic-to-pulmonary artery shunt is certainly lower than that of a vascular graft interposed in venous position, but it is still reported to be high (up to 20%) at intermediate follow-up [2,3]. Continued postoperative oral anticoagulation with coumadin preserved the patency of the goretex prosthesis allowing the growth of the right pulmonary artery branch.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |